Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Noradrenergic Modulation of Cognition in Health and Disease.

Borodovitsyna O, Flamini M, Chandler D.

Neural Plast. 2017;2017:6031478. doi: 10.1155/2017/6031478. Epub 2017 May 3. Review.

2.

Methamphetamine-Associated Psychosis and Treatment With Haloperidol and Risperidone: A Pilot Study.

Samiei M, Vahidi M, Rezaee O, Yaraghchi A, Daneshmand R.

Iran J Psychiatry Behav Sci. 2016 Sep 4;10(3):e7988. eCollection 2016 Sep.

3.

Methamphetamine psychosis: epidemiology and management.

Glasner-Edwards S, Mooney LJ.

CNS Drugs. 2014 Dec;28(12):1115-26. doi: 10.1007/s40263-014-0209-8. Review.

4.

Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort.

Kalayasiri R, Verachai V, Gelernter J, Mutirangura A, Malison RT.

Addiction. 2014 Jun;109(6):965-76. doi: 10.1111/add.12512. Epub 2014 Mar 17.

5.

Amphetamine-induced psychosis--a separate diagnostic entity or primary psychosis triggered in the vulnerable?

Bramness JG, Gundersen ØH, Guterstam J, Rognli EB, Konstenius M, Løberg EM, Medhus S, Tanum L, Franck J.

BMC Psychiatry. 2012 Dec 5;12:221. doi: 10.1186/1471-244X-12-221. Review.

6.

Role of serine racemase in behavioral sensitization in mice after repeated administration of methamphetamine.

Horio M, Kohno M, Fujita Y, Ishima T, Inoue R, Mori H, Hashimoto K.

PLoS One. 2012;7(4):e35494. doi: 10.1371/journal.pone.0035494. Epub 2012 Apr 18.

7.
8.

No Association Between GRM3 and Japanese Methamphetamine-Induced Psychosis.

Tsunoka T, Kishi T, Ikeda M, Kitajima T, Yamanouchi Y, Kinoshita Y, Kawashima K, Okochi T, Okumura T, Inada T, Ujike H, Yamada M, Uchimura N, Sora I, Iyo M, Ozaki N, Iwata N.

Curr Neuropharmacol. 2011 Mar;9(1):160-2. doi: 10.2174/157015911795017001.

9.

Methamphetamine induces endoplasmic reticulum stress related gene CHOP/Gadd153/ddit3 in dopaminergic cells.

Irie Y, Saeki M, Tanaka H, Kanemura Y, Otake S, Ozono Y, Nagai T, Kondo Y, Kudo K, Kamisaki Y, Miki N, Taira E.

Cell Tissue Res. 2011 Aug;345(2):231-41. doi: 10.1007/s00441-011-1207-5. Epub 2011 Jul 26.

11.

The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population.

Kobayashi H, Ujike H, Iwata N, Inada T, Yamada M, Sekine Y, Uchimura N, Iyo M, Ozaki N, Itokawa M, Sora I.

Behav Brain Funct. 2010 Aug 30;6:50. doi: 10.1186/1744-9081-6-50.

12.

Methamphetamine and paranoia: the methamphetamine experience questionnaire.

Leamon MH, Flower K, Salo RE, Nordahl TE, Kranzler HR, Galloway GP.

Am J Addict. 2010 Mar-Apr;19(2):155-68. doi: 10.1111/j.1521-0391.2009.00014.x.

13.

Does context influence the duration of locomotor sensitization to ethanol in female DBA/2J mice?

Boehm SL 2nd, Goldfarb KJ, Serio KM, Moore EM, Linsenbardt DN.

Psychopharmacology (Berl). 2008 Apr;197(2):191-201. Epub 2007 Nov 30.

14.

The behavioral actions of lithium in rodent models: leads to develop novel therapeutics.

O'Donnell KC, Gould TD.

Neurosci Biobehav Rev. 2007;31(6):932-62. Epub 2007 Apr 13. Review.

15.

The need for speed: an update on methamphetamine addiction.

Barr AM, Panenka WJ, MacEwan GW, Thornton AE, Lang DJ, Honer WG, Lecomte T.

J Psychiatry Neurosci. 2006 Sep;31(5):301-13. Review.

16.

Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function.

Richtand NM.

Neuropsychopharmacology. 2006 Nov;31(11):2368-75. Epub 2006 Jul 19. Review.

17.

Symbiotic relationship of pharmacogenetics and drugs of abuse.

Rutter JL.

AAPS J. 2006 Mar 24;8(1):E174-84. Review.

Supplemental Content

Support Center